Company / Operating Margin
Arcutis Biotherapeutics, Inc. Operating Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-3.3%
FY2025
5-year range
-65.3% / -3.3%
FY2024-FY2025
Trend
+95.0%
vs FY2024
Sector context
#54 of 135
Health Care
What the data says
At -3.3%, Arcutis Biotherapeutics, Inc.'s operating margin ranks #54 of 135 in the Health Care sector.
Based on SEC 10-K filings.
-3.3% in FY2025.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#54 of 135 in Health CareTop 40% of 135This company -3.3% Sector average -774.4%
▼
+99.6% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 95.0% year-over-year.
- Currently 771.2pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.3% | +95.0% |
| FY2024 | -65.3% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026